News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

PERCIVIA LLC Appoints Dr. Michael Wyand Vice President, Global Operations and Nicholas Plumeridge Vice President, Global Business Development


9/6/2011 11:02:24 AM

CAMBRIDGE, Mass.--(BUSINESS WIRE)--PERCIVIA LLC, (“PERCIVIA”) named Dr. Michael Wyand the Vice President of Global Operations and Nicholas Plumeridge the Vice President of Global Business Development. PERCIVIA is a venture formed by Crucell N.V. and Royal DSM N.V., to develop recombinant therapeutic proteins using the PER.C6® human cell line, with a focus on bio-similar monoclonal antibodies globally. Additionally, PERCIVIA outlicenses the PER.C6®cell line and provides logistical support by training and advising on the methods of recombinant protein production using the technology provided to licensees.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES